4588 · Oncolys BioPharma Inc. · Financials
Market Cap
225.81B JPY
Shares
29.44M
Volume · Nov 12
1.27M
Avg daily vol (3M)
1.78M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
28.55M
-9%
FY2025
Net Income
-2.06B
-22.2%
FY2025
Gross Margin
100%
0pp
FY2025
Operating Margin
-7090.55%
-1733pp
FY2025
Operating Cash Flow
-1.94B
+3.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| JPY | 28.55M | 31.38M | 63.04M | 976.18M | 642.49M | 314.18M | 1.3B | 168.55M | 229.14M |
| JPY | 28.55M | 31.38M | 30.6M | 338.49M | 198.8M | 236.11M | 1.19B | 47.22M | 157.58M |
| JPY | -2.02B | -1.68B | -1.93B | -1.2B | -1.45B | -1.67B | -511.46M | -1.25B | -1.08B |
| JPY | -2.05B | -1.68B | -1.94B | -1.15B | -1.61B | -2.09B | -908.59M | -1.23B | -1.09B |
| JPY | 4.03M | 3.76M | 2.93M | 2.93M | 3.73M | 3.73M | 3.75M | 3.74M | 3.52M |
| JPY | -2.06B | -1.68B | -1.94B | -1.15B | -1.62B | -2.1B | -912.35M | -1.23B | -1.09B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.